No black box warning on record for Zevalin
As of the latest FDA labeling reviewed, Zevalin (IBRITUMOMAB TIUXETAN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Zevalin medicine page for the complete safety profile.